(Total Views: 417)
Posted On: 12/23/2018 12:02:44 PM
Post# of 72441
Re: Commando911 #52268
You are correct - as a long term shareholder here, I consider these times to be tough for reasons that include, but are not limited to:
Cratering share price, with no end in sight: What’s left of a $10M facility to pay for bringing whatever compounds are left through Phase 2/3 trials, and cover salaries & bonuses.
Been over two years since Bertolino & Harness were added to the payroll, and I am looking for evidence of the value they have brought to shareholders (Partnerships? Compounds to market?)
I will continue to dig through the last year’s PRs to find the timeline that Management should have provided showing how long it will take to get the Company’s remaining compounds to market, and how much they think it will cost, assuming that the remaining compounds meet their respective trial endpoints.
Merry Christmas to you, Commando911 - may we all be rewarded soon.
Cratering share price, with no end in sight: What’s left of a $10M facility to pay for bringing whatever compounds are left through Phase 2/3 trials, and cover salaries & bonuses.
Been over two years since Bertolino & Harness were added to the payroll, and I am looking for evidence of the value they have brought to shareholders (Partnerships? Compounds to market?)
I will continue to dig through the last year’s PRs to find the timeline that Management should have provided showing how long it will take to get the Company’s remaining compounds to market, and how much they think it will cost, assuming that the remaining compounds meet their respective trial endpoints.
Merry Christmas to you, Commando911 - may we all be rewarded soon.
(1)
(0)Scroll down for more posts ▼
